Text messaging improves health of Kenyans with HIV
Lancet article by NGDI Associate Dr. Richard Lester highlights mHealth at work in Kenya.
Dr. Tobias Kollmann heads structured collaboration with Advaxis, Inc.
Kollmann lab agreement with Advaxis worth $465,000 over five years.
Advaxis & Kollmann Lab to Collaborate on Infectious Disease Vaccines
Oral Amphotericin B Program Receives FDA Orphan Drug Status
iCo Therapeutics Inc. is pleased to announce that the Company’s oral Amphotericin B program, “iCo-009”, has been granted Orphan Drug status for the treatment of Visceral Leishmaniasis by the US Food and Drug Administration.
iCo Therapeutics Appoints Infectious Disease Experts to Scientific Advisory Board
iCo Therapeutics Inc. appoints experts to scientific advisory board for Kishor Wasan’s oral Amphotericin B project.
International Fellowship Training Program
New Global Pediatric Infectious Diseases (GpID), International Fellowship Training Program
See posting under Education/Training.
Richard Lester to speak at 2010 mHealth Summit
Dr. Richard Lester in the Faculty of Medicine, Department of Infectious Diseases has been accepted to speak at the 2010 mHealth Summit in Washington, DC on November 9.
Accessible Science Initiative – UBC Students in Columbia
The Accessible Science Initiative team are back from Columbia and the trip was a great success. See the UBC Reports story for more details (link in main story).
NGDI Associate receives $300K funding for 3 year Dengue Study
Originally published on May 31, 2010 Principal Investigators Jerry Spiegel (UBC School of Population and Public Health), Jaime Breilh (Universidad Andina Simon Bolivar, Ecuador) and Efrain Beltrán (Universidada Técnica de Machala), are meeting capacity-building and scaling-up challenges to sustainably prevent and control Dengue Fever in Machala, Ecuador. The project aims to evaluate the effectiveness, cost […]
NGDI Associates call for “social offsets” to tackle neglected tropical diseases
Originally published on May 18, 2010 Which New Approaches to Tackling Neglected Tropical Diseases Show Promise? Spiegel JM, Dharamsi S, Wasan KM, Yassi A, Singer B, et al. 2010 Which New Approaches to Tackling Neglected Tropical Diseases Show Promise?. PLoS Med 7(5): e1000255. doi:10.1371/journal.pmed.1000255 Public health and international development experts at the University of British […]
CIHR grant for malaria research awarded to NGDI Associate, Dr. Rosemin Kassam
Originally published on March 18, 2010 NGDI -UBC is pleased to announce that Dr. Rosemin Kassam is the recipient of a CIHR Catalyst Grant in Primary and Community-Based Healthcare. Dr. Kassam’s project will partner with Makarere University (Kampala, Uganda) to develop a community program for reducing malaria related child mortality in Uganda.